Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06541860
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-04-09
Brief Title:
DAratumumab and REvlimid REfractory MM
Sponsor:
Organization:
None